Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
5.31
+0.13 (2.51%)
At close: Sep 11, 2026, 4:00 PM EDT
5.31
0.00 (0.00%)
After-hours: Sep 11, 2026, 4:10 PM EDT
Atea Pharmaceuticals Market Cap
Atea Pharmaceuticals has a market cap or net worth of $425.89 million as of September 11, 2026. Its market cap has increased by 70.37% in one year.
Market Cap
425.89M
Enterprise Value
206.85M
1-Year Change
70.37%
Ranking
Category
Stock Price
$5.31
ChartMarket Cap Chart
Since the IPO on October 30, 2020, Atea Pharmaceuticals's market cap has decreased from $1.94B to $425.89M, a decrease of -78.02%. That is a compound annual growth rate of -22.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 425.89M | 52.70% |
| Dec 31, 2025 | 278.91M | -1.43% |
| Dec 31, 2024 | 282.95M | 11.19% |
| Dec 29, 2023 | 254.48M | -36.48% |
| Dec 30, 2022 | 400.61M | -46.08% |
| Dec 31, 2021 | 742.94M | -78.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 30, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Evommune | 474.70M |
| Ginkgo Bioworks Holdings | 467.34M |
| Editas Medicine | 465.35M |
| Rezolute | 459.65M |
| Relmada Therapeutics | 453.35M |
| Ocugen | 451.02M |
| Vogenx | 445.36M |
| Arcturus Therapeutics Holdings | 444.25M |